Martin Jenkins Selected Research

Martin Jenkins Research Topics

20	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 09/2011
2	Lung Diseases (Lung Disease) 08/2021 - 04/2012
2	Dyspnea (Shortness of Breath) 08/2021 - 04/2012
2	Inflammation (Inflammations) 09/2017 - 09/2011
2	Neoplasms (Cancer) 05/2013 - 07/2010
1	Synovitis 09/2017
1	Rheumatoid Arthritis 09/2017
1	Disease Progression 04/2012
1	Respiratory Signs and Symptoms 04/2012
1	Cough 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 07/2010

15	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 04/2012
13	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2018
8	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 04/2012
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2021
6	Muscarinic AntagonistsIBA 10/2021 - 01/2019
5	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 10/2021 - 01/2021
5	Bronchodilator Agents (Bronchodilators)IBA 05/2020 - 04/2012
4	Biomarkers (Surrogate Marker)IBA 09/2017 - 09/2011
3	SuspensionsIBA 01/2020 - 01/2018
2	GoldIBA 01/2020 - 08/2013
1	2- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA 05/2020
1	Adalimumab (Humira)FDA Link 09/2017
1	fostamatinibIBA 09/2017
1	Secretory Proteinase Inhibitory ProteinsIBA 04/2012
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2012
1	N- ((5- (methanesulfonyl)pyridin- 2- yl)methyl)- 6- methyl- 5- (1- methyl- 1H- pyrazol- 5- yl)- 2- oxo- 1- (3- (trifluoromethyl)phenyl)- 1,2- dihydropyridine- 3- carboxamideIBA 04/2012
1	Biological ProductsIBA 09/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2010
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2010
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2010
1	AntibodiesIBA 07/2010

14	Therapeutics 01/2022 - 07/2010
10	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 01/2018
1	Dry Powder Inhalers 01/2022